| Hypotonia |
- Central: Cerebral palsy, metabolic disorders.
- Peripheral: Myopathies, neuropathies.
- Spinal: SMA
Causes and Underlying Mechanisms of Hypotonia
Hypotonia arises from a complex interplay of genetic, congenital, metabolic, infectious, and environmental factors that disrupt neuromuscular integrity. The underlying mechanisms often involve dysfunction in the central nervous system (CNS), peripheral nerves, neuromuscular junctions, or muscle tissue itself. Genetic mutations, prenatal insults, metabolic imbalances, and acquired injuries collectively contribute to the spectrum of hypotonia observed across different age groups and clinical presentations.The pathophysiological pathways linking CNS dysfunction to hypotonia typically involve disruptions in motor neuron signaling, reduced muscle tone regulation, or impaired excitation-contraction coupling. Key biochemical markers, such as elevated creatine kinase (CK) in muscular dystrophies or abnormal lactate levels in mitochondrial disorders, serve as diagnostic indicators. Below, the genetic, congenital, non-genetic, and environmental causes are systematically categorized, followed by a structured overview of rare but critical etiologies.
Genetic and Congenital Causes of Hypotonia
Genetic mutations account for a significant proportion of hypotonia cases, often presenting as part of syndromic or isolated neuromuscular disorders. These mutations may affect motor neurons, muscle structure, or neurotransmitter synthesis, leading to reduced muscle tone and strength. Syndromic hypotonia frequently co-occurs with intellectual disability, dysmorphic features, or other systemic abnormalities, while isolated forms may present with muscle weakness alone.Syndromes Associated with Hypotonia
The following table summarizes key genetic syndromes linked to hypotonia, their primary genetic defects, and hallmark clinical features:
| Syndrome |
Primary Genetic Defect |
Key Clinical Features |
Pathophysiological Mechanism |
|---|
| Down Syndrome (Trisomy 21) |
Triplication of chromosome 21 |
Hypotonia in infancy, developmental delay, dysmorphic facial features, congenital heart defects |
Altered neuronal migration and synaptic pruning due to overexpression of genes such as DYRK1A and APP. |
| Prader-Willi Syndrome |
Deletion or maternal disomy of chromosome 15q11-q13 |
Neonatal hypotonia, hyperphagia, obesity, intellectual disability, hypogonadism |
Loss of imprinted genes (e.g., SNRPN, NDN) disrupts hypothalamic function and muscle development. |
| Spinal Muscular Atrophy (SMA) |
Deletion or mutation in SMN1 gene (5q11.2-q13.3) |
Proximal muscle weakness, hypotonia, fasciculations, respiratory insufficiency |
Reduced survival motor neuron (SMN) protein leads to motor neuron degeneration and denervation atrophy. |
| Duchenne/Becker Muscular Dystrophy |
Mutations in DMD gene (Xp21.2) |
Progressive muscle weakness, calf pseudohypertrophy, cardiomyopathy, respiratory failure |
Absence or dysfunction of dystrophin disrupts muscle membrane integrity, leading to fibrosis and necrosis. |
| Fragile X Syndrome |
CGG repeat expansion in FMR1 gene (Xq27.3) |
Hypotonia, intellectual disability, macroorchidism, autistic traits |
Loss of fragile X mental retardation protein (FMRP) impairs synaptic plasticity and dendritic spine maturation. |
Isolated Genetic Disorders
Beyond syndromic presentations, mutations in genes encoding structural or functional muscle proteins contribute to non-syndromic hypotonia. Examples include:
- Congenital Myopathies: Mutations in RYR1 (central core disease), SEPN1 (multiminicore disease), or ACTA1 (nemaline myopathy) disrupt sarcomeric structure, leading to hypotonia and contractures.
- Neurodevelopmental Disorders: Mutations in KIF1A or TUBB3 impair axonal transport or microtubule assembly, resulting in hypotonia and developmental regression.
- Channelopathies: Mutations in voltage-gated sodium (SCN4A) or calcium (CACNA1S) channels cause congenital myasthenic syndromes or periodic paralysis, characterized by fluctuating weakness and hypotonia.
Non-Genetic Congenital Causes of Hypotonia
Non-genetic congenital causes of hypotonia stem from prenatal or perinatal insults that disrupt neuromuscular development. These may include infections, metabolic disturbances, or structural abnormalities affecting the CNS or muscle tissue. Early identification of these etiologies is critical for timely intervention and prognostic counseling.Infectious and Inflammatory Causes
Prenatal infections, particularly those causing encephalitis or myositis, can lead to permanent hypotonia. Notable pathogens include:
- Toxoplasmosis: Caused by Toxoplasma gondii, leading to hydrocephalus, intracranial calcifications, and hypotonia due to CNS inflammation.
- Rubella: Congenital rubella syndrome may result in microcephaly, cataracts, and hypotonia from viral damage to developing neurons and glial cells.
- Cytomegalovirus (CMV): Intrauterine CMV infection is a leading cause of sensorineural hearing loss and hypotonia, mediated by neuronal apoptosis and demyelination.
- Herpes Simplex Virus (HSV): Neonatal HSV encephalitis often presents with hypotonia, seizures, and developmental delay due to temporal lobe necrosis.
Metabolic Disorders
Inborn errors of metabolism disrupt energy production, neurotransmitter synthesis, or structural protein assembly, leading to hypotonia. Key categories include:
- Mitochondrial Disorders: Defects in oxidative phosphorylation (e.g., MT-ATP6 mutations in MELAS syndrome) cause lactic acidosis, exercise intolerance, and hypotonia due to impaired ATP generation in muscle and nerve cells.
- Organic Acidemias: Disorders such as propionic acidemia (PCCA or PCCB mutations) or methylmalonic acidemia (MUT mutations) lead to metabolic acidosis, encephalopathy, and hypotonia from toxic metabolite accumulation.
- Lysosomal Storage Diseases: Enzyme deficiencies (e.g., GAA in Pompe disease, HEXA in Tay-Sachs) result in glycogen or glycolipid accumulation in muscle and nerve cells, causing hypotonia and organomegaly.
- Amino Acid Disorders: Phenylketonuria (PAH mutations) or maple syrup urine disease (BCKDH mutations) impair neurotransmitter synthesis, leading to hypotonia and intellectual disability if untreated.
Traumatic and Structural Causes
Perinatal injuries or structural abnormalities can directly damage motor pathways or muscle tissue:
- Birth Trauma: Shoulder dystocia or hypoxic-ischemic encephalopathy (HIE) may cause cerebral palsy (CP) with hypotonic subtypes, particularly spastic quadriplegia or dyskinetic CP.
- Cerebral Malformations: Conditions such as lissencephaly (LIS1 or TUBA1A mutations) or holoprosencephaly disrupt cortical organization, leading to severe hypotonia and developmental stagnation.
- Spinal Cord Injuries: Congenital spinal dysraphism (e.g., myelomeningocele) or traumatic lesions interrupt motor neuron pathways, resulting in flaccid paralysis and hypotonia below the lesion level.
Environmental and Acquired Causes of Hypotonia
Environmental exposures and acquired conditions in infancy or adulthood can induce hypotonia through toxin-induced neurotoxicity, nutritional deficiencies, or systemic illnesses. These causes are often modifiable or preventable with early intervention.Toxin Exposure
Prenatal or postnatal exposure to neurotoxic agents disrupts neuromuscular function:
- Alcohol: Fetal alcohol spectrum disorder (FASD) causes hypotonia, microcephaly, and behavioral abnormalities due to ethanol-induced neuronal apoptosis and reduced neurogenesis.
- Lead Poisoning: Chronic lead exposure (Pb) inhibits delta-aminolevulinic acid dehydratase (ALAD), leading to peripheral neuropathy, encephalopathy
Symptoms and Clinical Presentation of Hypotonia Across the Lifespan
Hypotonia manifests distinctively across developmental stages, with physical and functional consequences varying in severity and progression. In infants, symptoms often reflect delayed neuromuscular maturation, while in children and adults, hypotonia may contribute to chronic musculoskeletal and systemic complications. Understanding these stage-specific presentations enables targeted clinical assessment, early intervention, and improved quality of life. Below, the clinical features are categorized by age group, functional impact, and red flag indicators requiring urgent evaluation.
Developmental Stage-Specific Symptoms in Infants and Young Children
In infancy, hypotonia is frequently identified through motor delays and postural abnormalities, which may suggest underlying neurological or genetic disorders. The "ragdoll" appearance—characterized by excessive joint laxity and a tendency to flop when held upright—is a hallmark sign. Infants with hypotonia often exhibit poor head control beyond the expected developmental window (typically by 4–6 months), delayed rolling over (beyond 6–7 months), and difficulty sitting independently (beyond 8–9 months). Fine motor skills, such as reaching for objects or grasping toys, may also lag, with infants demonstrating weak palmar grasp or an inability to sustain hand movements.Gross motor milestones are particularly affected, with children achieving crawling (beyond 10–12 months) and walking independently (beyond 15–18 months) later than peers. Feeding difficulties are common due to poor suck-swallow coordination, leading to choking, gagging, or failure to thrive. Respiratory complications, such as hypoventilation or recurrent pneumonia, may arise from weakness of intercostal and diaphragmatic muscles. Speech development may be delayed due to oral motor hypotonia, resulting in nasal speech, dysarthria, or difficulty forming sounds. Case Study Example (Pediatric):
A 6-month-old infant presented with persistent head lag, inability to roll from supine to prone, and a "floppy" body when lifted. Physical examination revealed generalized hypotonia with 3/5 proximal muscle strength (Medical Research Council scale) and hyperreflexia. Genetic testing later identified a prune belly syndrome variant, necessitating early physical therapy and respiratory monitoring.
Clinical Presentation in School-Age Children and Adolescents
As children grow, hypotonia often transitions from gross motor delays to fatigue, joint instability, and compensatory movement patterns. Frequent falls and clumsiness are common due to weakness in proximal muscles (e.g., shoulders, hips), leading to poor balance and difficulty with dynamic activities (e.g., running, jumping). Scoliosis or kyphosis may develop secondary to muscle imbalances and ligamentous laxity, requiring orthopedic intervention. Speech and language delays persist, with articulation disorders and reduced vocal volume due to pharyngeal and laryngeal hypotonia.Fine motor skills remain challenging, with difficulties in handwriting, buttoning clothes, or using utensils due to weak intrinsic hand muscles. Fatigue becomes a significant limiting factor, particularly in sustained activities (e.g., sports, prolonged sitting). Sleep disturbances may occur secondary to respiratory insufficiency or chronic pain from joint hypermobility. Case Study Example (Adolescent):
A 12-year-old child with congenital myotonic dystrophy exhibited progressive proximal weakness, requiring a wheelchair by age 14. Clinical features included shoulder girdle hypotonia, pes planus (flat feet), and respiratory insufficiency necessitating non-invasive ventilation. Physical therapy focused on energy conservation techniques and orthotic support to prevent contractures.
Symptoms and Complications in Adults with Hypotonia
In adulthood, hypotonia often leads to chronic musculoskeletal pain, joint instability, and systemic complications that impair independence. Proximal muscle weakness (e.g., hips, shoulders) results in difficulty with transfers (e.g., getting out of chairs), climbing stairs, or maintaining upright posture. Distal hypotonia affects fine motor tasks, such as typing, driving, or using tools, leading to functional dependence in daily activities.Respiratory complications become critical, with diaphragmatic weakness causing sleep-disordered breathing, hypoxemia, or requiring mechanical ventilation. Swallowing dysfunction (oropharyngeal hypotonia) increases the risk of aspiration pneumonia and malnutrition. Chronic pain is prevalent due to joint hypermobility, ligamentous laxity, and muscle overuse injuries. Fatigue is often debilitating, limiting work capacity and social participation. Case Study Example (Adult):
A 35-year-old woman with spinal muscular atrophy type III presented with progressive proximal weakness, scoliosis, and respiratory failure. She required bipap ventilation at night and used a walker for ambulation. Physical therapy emphasized breathing exercises, energy-efficient movement strategies, and orthopedic bracing to prevent contractures.
Muscle Group-Specific Manifestations and Functional Impact
Hypotonia does not affect all muscle groups uniformly, and its distribution influences functional limitations. Proximal hypotonia (shoulders, hips, trunk) impairs postural control, gait stability, and transfers, while distal hypotonia (hands, feet) disrupts fine motor precision and grip strength. Below is a summary of muscle group-specific effects:
| Muscle Group | Symptoms | Functional Impact |
|---|
| Axial (Trunk) | Poor sitting balance, scoliosis, difficulty standing from supine | Impaired mobility, risk of falls, respiratory compromise |
| Proximal (Shoulders/Hips) | Weakness in lifting arms/legs, waddling gait, Gower’s maneuver (using hands to stand) | Limited ambulation, difficulty with self-care (e.g., dressing, toileting) |
| Distal (Hands/Feet) | Weak grasp, dropped objects, foot deformities (e.g., pes planus) | Impaired fine motor tasks (writing, feeding), gait abnormalities |
| Oropharyngeal | Nasal speech, dysphagia, choking during meals | Risk of aspiration, malnutrition, speech intelligibility issues |
| Respiratory | Shallow breathing, early fatigue with exertion, sleep apnea | Hypoxemia, recurrent infections, need for ventilatory support |
Key Consideration:
Hypotonia in proximal muscles often precedes distal involvement, with axial weakness being the most functionally limiting due to its impact on posture and respiration.
Certain symptoms in hypotonia warrant urgent investigation to identify underlying treatable or progressive conditions. Below is a table of red flags, including possible etiologies and recommended diagnostic tests:
| Symptom |
Possible Underlying Cause |
Recommended Diagnostic Test |
|---|
| Sudden onset of hypotonia in an otherwise healthy child |
Acute metabolic disorder (e.g., mitochondrial disease), spinal cord injury, botulism |
Urgent metabolic panel, spinal MRI, stool toxin assay |
| Progressive weakness with bulbar involvement (dysphagia, dysarthria) |
Motor neuron disease (e.g., SMA, ALS), muscular dystrophy |
Electromyography (EMG), genetic testing (SMN1 gene), muscle biopsy |
| Hypotonia with hyperreflexia and clonus |
Upper motor neuron lesions (e.g., cerebral palsy, spinal cord trauma) |
Brain/spinal MRI, EEG (if seizures present), genetic testing (e.g., ARX, L1CAM) |
| Hypotonia with cataracts, cardiac abnormalities, or hepatomegaly |
Inborn errors of metabolism (e.g., Pompe disease, congenital myotonic dyst
The accurate diagnosis of hypotonia requires a structured, multimodal evaluation integrating clinical assessment, advanced diagnostic tools, and laboratory investigations. Early and precise identification of underlying causes is critical for guiding targeted management, prognostic counseling, and potential therapeutic interventions. The diagnostic process begins with a meticulous patient history and physical examination, followed by specialized tests to differentiate between neuromuscular, metabolic, structural, and systemic etiologies.Diagnostic strategies must account for the heterogeneous nature of hypotonia, where symptoms may overlap with other conditions such as joint hypermobility, depression-related muscle weakness, or medication-induced myopathy. A systematic approach ensures that no potential cause is overlooked, particularly in cases where hypotonia presents as an isolated feature or part of a broader syndrome.
Clinical Evaluation and Patient History Assessment
A comprehensive clinical evaluation forms the foundation of hypotonia diagnosis, combining patient-reported symptoms, family history, and objective physical findings. The assessment focuses on identifying patterns of muscle weakness, associated neurological deficits, and systemic manifestations that may suggest specific etiologies.Patient History Assessment
The medical history should explore:
- Onset and progression: Acute vs. gradual onset, age of symptom appearance, and stability or deterioration over time.
- Family history: Inheritance patterns (autosomal recessive, dominant, X-linked) and presence of consanguinity, which may indicate genetic disorders (e.g., spinal muscular atrophy, congenital myopathies).
- Prenatal and perinatal factors: Maternal infections, exposure to teratogens, preterm birth, or birth asphyxia, which may correlate with hypoxic-ischemic encephalopathy or cerebral palsy.
- Developmental milestones: Delays in motor skills (e.g., sitting, standing, walking) or regression, which are common in neurodegenerative or metabolic disorders.
- Associated symptoms: Feeding difficulties, respiratory distress, seizures, or cognitive impairments, which may point to specific syndromes (e.g., Prader-Willi syndrome, mitochondrial disorders).
- Medication and environmental exposures: Recent antibiotic use (e.g., daptomycin-induced myopathy), statin therapy, or exposure to neurotoxic agents.
Physical Examination
A standardized physical examination evaluates muscle tone, strength, and neurological integrity. Key components include:
- Muscle tone assessment: Passive movement of major joints (e.g., elbows, knees, hips) to detect reduced resistance to movement, particularly in proximal muscles.
- Deep tendon reflex (DTR) testing: Hyporeflexia or areflexia may suggest lower motor neuron disorders (e.g., spinal muscular atrophy), while hyperreflexia or clonus may indicate upper motor neuron involvement (e.g., cerebral palsy).
- Muscle strength grading: Manual muscle testing (MMT) using the Medical Research Council (MRC) scale (0–5) to quantify weakness, with proximal > distal weakness favoring myopathic or neuromuscular junction disorders.
- Joint assessment: Hypermobility or contractures may indicate connective tissue disorders (e.g., Ehlers-Danlos syndrome) or chronic hypotonia.
- Neurological screening: Evaluation of cranial nerves, coordination, sensation, and presence of fasciculations or muscle atrophy, which may localize lesions to specific pathways.
Red Flags in Clinical Presentation
- Symmetrical proximal weakness with preserved reflexes → Consider muscular dystrophies or metabolic myopathies.
- Asymmetrical weakness with fasciculations → Suggests motor neuron disease (e.g., ALS).
- Ophthalmoplegia or ptosis → May indicate mitochondrial or congenital myasthenic syndromes.
- Cardiomyopathy or respiratory insufficiency → Points to dystrophinopathies or congenital myopathies.
- Developmental regression → Warrants evaluation for storage diseases (e.g., Pompe disease) or neurodegenerative disorders.
Advanced diagnostic tools are employed to elucidate the underlying pathology when clinical findings are inconclusive or suggest specific etiologies. Selection of tests depends on the suspected mechanism (neuromuscular, metabolic, structural, or systemic) and the patient’s clinical profile.Electrodiagnostic Studies
Electromyography (EMG) and nerve conduction studies (NCS) assess the integrity of the neuromuscular junction, peripheral nerves, and muscle fibers.
- Indications:
- Distinguishing between myopathic (short-duration, small-amplitude motor unit potentials) and neurogenic (long-duration, high-amplitude potentials) patterns.
- Detecting denervation (fibrillations, positive sharp waves) in motor neuron diseases.
- Evaluating repetitive nerve stimulation (RNS) for myasthenia gravis or Lambert-Eaton syndrome.
- Limitations:
- False negatives in early-stage disorders or with partial denervation.
- Pain or discomfort during needle insertion, limiting cooperation in pediatric or anxious patients.
Muscle Biopsy
A targeted muscle biopsy provides histopathological and enzymatic analysis to identify structural abnormalities, storage disorders, or mitochondrial dysfunction.
- Indications:
- Suspected congenital myopathies (e.g., nemaline myopathy, central core disease).
- Metabolic myopathies (e.g., glycogen or lipid storage disorders).
- Inflammatory or autoimmune myopathies (e.g., dermatomyositis, inclusion body myositis).
- Procedure:
- Typically performed on the vastus lateralis or deltoid muscles under local anesthesia.
- Samples are analyzed for fiber size variability, abnormal inclusions, oxidative enzyme activity, and immunohistochemical staining (e.g., dystrophin, dysferlin).
- Limitations:
- Invasive with potential complications (e.g., hematoma, infection).
- Sampling error if the biopsy misses affected areas.
Genetic Testing
Genetic evaluation is critical for diagnosing hereditary hypotonia, particularly in pediatric cases or when a familial pattern is present.
- Approaches:
- Targeted gene testing: For known mutations (e.g., SMN1 in spinal muscular atrophy, DMD in Duchenne muscular dystrophy).
- Exome/genome sequencing: Broad panels for undiagnosed cases, covering genes associated with neuromuscular, metabolic, and syndromic hypotonia.
- Chromosomal microarray (CMA): Detects copy number variations (CNVs) in patients with intellectual disability or dysmorphic features.
- Indications:
- Congenital hypotonia with normal imaging and electrodiagnostics.
- Family history of neuromuscular disorders.
- Associated features such as dysmorphisms, organomegaly, or metabolic decompensation.
- Limitations:
- High cost and variability in gene panel coverage.
- Variants of uncertain significance (VUS) may complicate interpretation.
Imaging Techniques in Hypotonia Diagnosis
Neuroimaging plays a pivotal role in identifying structural abnormalities in the brain, spinal cord, and muscles that may underlie hypotonia. The choice of modality depends on the suspected pathology, patient age, and availability of resources.
| Technique |
Purpose |
Limitations |
Sample Findings |
|---|
| MRI (Magnetic Resonance Imaging) |
- Assess brain parenchyma for malformations (e.g., lissencephaly, polymicrogyria), white matter changes (leukodystrophies), or atrophy.
- Evaluate spinal cord for syringomyelia, Chiari malformations, or spinal muscular atrophy (SMA)-related anterior horn cell atrophy.
- Detect muscle fatty infiltration in chronic myopathies.
|
- Expensive and time-consuming; requires sedation in infants.
- Artifacts from motion or metallic objects.
- Limited sensitivity for early or mild neuromuscular changes.
|
- Cerebellar hypoplasia in Joubert syndrome.
- T2-hyperintense lesions in mitochondrial disorders (e.g., MELAS).
- High signal on STIR sequences in muscular dystrophies.
|
| CT Scan (Computed Tomography) |
- Rapid assessment of bony structures (e.g., spinal deformities, craniosynostosis).
- Detection of muscle atrophy or calcification (e.g., myositis ossificans).
- Evaluation of chest wall abnormalities in respiratory hypotonia.
|
- Lower soft tissue contrast resolution than MRI.
- Exposure to ionizing radiation; less ideal for repeated imaging.
Hypotonia embodies a multifaceted challenge at the intersection of neurology, genetics, and developmental medicine, demanding precision in diagnosis and adaptability in treatment. From the "ragdoll" posture of infants to the respiratory complications faced by adults, its manifestations reflect the intricate balance between central nervous system integrity and peripheral muscle function. By leveraging comparative analyses—such as the distinctions between central, peripheral, and spinal hypotonia—and integrating advanced diagnostic tools, clinicians can navigate its complex landscape. Ultimately, addressing hypotonia requires not only medical expertise but also a holistic understanding of its lifelong implications, ensuring tailored interventions that restore function and improve quality of life.
FAQ
What causes hypotonia in babies and what are its symptoms?
Hypotonia in babies (also called "floppy baby syndrome") is low muscle tone, often caused by neurological conditions (like spinal muscular atrophy or cerebral palsy), genetic disorders (e.g., Down syndrome), or complications during pregnancy/birth. Symptoms include poor head control, weak cry, delayed motor skills (like sitting or rolling), and joint hypermobility. Some babies may also experience feeding difficulties or breathing problems.
How does hypotonia in adults differ from hypotonia in children, and what are common causes?
Hypotonia in adults refers to reduced muscle tone that can result from nerve/muscle disorders (e.g., Guillain-Barré syndrome, myasthenia gravis, or peripheral neuropathy), chronic illnesses (like diabetes or thyroid disorders), or long-term steroid use. Unlike in children, adult hypotonia often stems from acquired conditions rather than congenital ones and may cause fatigue, balance issues, or difficulty with fine motor tasks. Diagnosis typically involves neurological exams and tests like EMG or blood work.
What are the signs of hypotonia in children, and how is it diagnosed?
Signs of hypotonia in children include delayed milestones (e.g., crawling, walking), frequent falling, unusually flexible joints, weak or "ragdoll-like" posture, and poor coordination. Diagnosis involves a physical exam to check muscle strength and reflexes, along with imaging (MRI/CT) or genetic testing to identify underlying causes like muscular dystrophy or metabolic disorders. Early intervention (physical therapy, occupational therapy) can improve outcomes.
What’s the difference between hypotonia and hypertonia, and can they occur together?
Hypotonia is low muscle tone with flaccid, weak muscles, while hypertonia is increased tone with stiff, rigid muscles (e.g., spasticity in stroke or cerebral palsy). They can occur separately or together—some conditions (like mixed cerebral palsy) show both patterns in different muscle groups. Hypotonia often precedes hypertonia in developmental disorders, reflecting changes in nervous system control over muscle tone.
Is hypotonia common in children with Down syndrome, and why?
Yes, hypotonia is very common in children with Down syndrome, affecting about 75% of infants with the condition. It results from delayed muscle development and neurological differences, including weaker reflexes and slower motor skill progression. While most children outgrow it, persistent hypotonia may contribute to delays in sitting, walking, or hand use, often requiring early physical therapy.
Is hypotonia considered a disease, or is it a symptom of other conditions?
Hypotonia itself is not a disease but a symptom of underlying disorders, which can range from genetic conditions (e.g., spinal muscular atrophy) to neurological or metabolic diseases. Rarely, it may be idiopathic (no identifiable cause), but it always indicates an issue with muscle control or nerve signaling. Treatment focuses on addressing the root cause, not hypotonia alone.
|
|
|
Leave a Comment
Comments are moderated before appearing. The data you submit is processed according to the Privacy Policy of Voltefac.